184 related articles for article (PubMed ID: 23880795)
1. Over-the-counter treatments and perineal hygiene in postmenopausal women.
Erekson EA; Martin DK; Brousseau EC; Yip SO; Fried TR
Menopause; 2014 Mar; 21(3):281-5. PubMed ID: 23880795
[TBL] [Abstract][Full Text] [Related]
2. Vaginal health and hygiene practices and product use in Canada: a national cross-sectional survey.
Crann SE; Cunningham S; Albert A; Money DM; O'Doherty KC
BMC Womens Health; 2018 Mar; 18(1):52. PubMed ID: 29566756
[TBL] [Abstract][Full Text] [Related]
3. Products used on female genital mucosa.
Farage MA; Lennon L; Ajayi F
Curr Probl Dermatol; 2011; 40():90-100. PubMed ID: 21325843
[TBL] [Abstract][Full Text] [Related]
4. Maintaining vulvar, vaginal and perineal health: Clinical considerations.
Graziottin A
Womens Health (Lond); 2024; 20():17455057231223716. PubMed ID: 38396383
[TBL] [Abstract][Full Text] [Related]
5. Exposure to Volatile Organic Compounds and Use of Feminine Hygiene Products Among Reproductive-Aged Women in the United States.
Ding N; Batterman S; Park SK
J Womens Health (Larchmt); 2020 Jan; 29(1):65-73. PubMed ID: 31532304
[No Abstract] [Full Text] [Related]
6. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
Kingsberg SA; Wysocki S; Magnus L; Krychman ML
J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
[TBL] [Abstract][Full Text] [Related]
7. Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions.
Palacios S; Cancelo MJ; Castelo Branco C; Llaneza P; Molero F; Borrego RS
Climacteric; 2017 Feb; 20(1):55-61. PubMed ID: 28042734
[TBL] [Abstract][Full Text] [Related]
8. Role of female intimate hygiene in vulvovaginal health: Global hygiene practices and product usage.
Chen Y; Bruning E; Rubino J; Eder SE
Womens Health (Lond); 2017 Dec; 13(3):58-67. PubMed ID: 28934912
[TBL] [Abstract][Full Text] [Related]
9. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders.
Erekson EA; Li FY; Martin DK; Fried TR
Menopause; 2016 Apr; 23(4):368-75. PubMed ID: 26645820
[TBL] [Abstract][Full Text] [Related]
10. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women.
Panay N; Palacios S; Bruyniks N; Particco M; Nappi RE;
Maturitas; 2019 Jun; 124():55-61. PubMed ID: 31097180
[TBL] [Abstract][Full Text] [Related]
11. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.
Nappi RE; Palacios S; Panay N; Particco M; Krychman ML
Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580
[TBL] [Abstract][Full Text] [Related]
12. Women's use of over-the-counter antifungal medications for gynecologic symptoms.
Ferris DG; Dekle C; Litaker MS
J Fam Pract; 1996 Jun; 42(6):595-600. PubMed ID: 8656170
[TBL] [Abstract][Full Text] [Related]
13. The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey.
Nappi RE; Palacios S; Bruyniks N; Particco M; Panay N;
Menopause; 2019 May; 26(5):485-491. PubMed ID: 30422932
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of Lactobacillus-containing feminine hygiene products on vaginal microbiome and genitourinary symptoms in pre- and postmenopausal women: A pilot randomized controlled trial.
Yoshikata R; Yamaguchi M; Mase Y; Tatsuyuki A; Myint KZY; Ohta H
PLoS One; 2022; 17(12):e0270242. PubMed ID: 36584204
[TBL] [Abstract][Full Text] [Related]
15. A question for women's health: chemicals in feminine hygiene products and personal lubricants.
Nicole W
Environ Health Perspect; 2014 Mar; 122(3):A70-5. PubMed ID: 24583634
[No Abstract] [Full Text] [Related]
16. Characteristics of external genitalia in pre- and postmenopausal women.
Basaran M; Kosif R; Bayar U; Civelek B
Climacteric; 2008 Oct; 11(5):416-21. PubMed ID: 18781487
[TBL] [Abstract][Full Text] [Related]
17. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
Gurwitz JH; McLaughlin TJ; Fish LS
Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
[TBL] [Abstract][Full Text] [Related]
18. Vaginitis: making sense of over-the-counter treatment options.
Angotti LB; Lambert LC; Soper DE
Infect Dis Obstet Gynecol; 2007; 2007():97424. PubMed ID: 18253469
[TBL] [Abstract][Full Text] [Related]
19. Douching behavior in high-risk adolescents. What do they use, when and why do they douche?
Oh MK; Merchant JS; Brown P
J Pediatr Adolesc Gynecol; 2002 Apr; 15(2):83-8. PubMed ID: 12057529
[TBL] [Abstract][Full Text] [Related]
20. Beyond douching: use of feminine hygiene products and STI risk among young women.
Ott MA; Ofner S; Fortenberry JD
J Sex Med; 2009 May; 6(5):1335-40. PubMed ID: 19170863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
